A detailed history of Cra Financial Services, LLC transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Cra Financial Services, LLC holds 11,000 shares of CABA stock, worth $14,080. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,000
Holding current value
$14,080
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 16, 2025

BUY
$1.39 - $2.74 $15,289 - $30,140
11,000 New
11,000 $15,000

Others Institutions Holding CABA

About Cabaletta Bio, Inc.


  • Ticker CABA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,014,000
  • Market Cap $37.1M
  • Description
  • Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...
More about CABA
Track This Portfolio

Track Cra Financial Services, LLC Portfolio

Follow Cra Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cra Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cra Financial Services, LLC with notifications on news.